{"timeline":{"headline":"Pharmacological Modulation of Cocaine Effects - 1","type":"default","text":"History of NCT00000201","startDate":"2005,06,23","date": [{"startDate":"2005,06,23","headline":"View of NCT00000201 on 2005_06_23","text":"<table class=\"info\">\n<tr>\n<th nowrap=\"\">ClinicalTrials Identifier:</th><td>NCT00000201</td>\n</tr>\n<tr>\n<th>Updated:</th><td>2005_06_23</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Descriptive Information</h2>\n</th>\n</tr>\n<tr>\n<th>Brief title</th><td>\n<p>Pharmacological Modulation of Cocaine Effects - 1</p>\n</td>\n</tr>\n<tr>\n<th>Official title</th><td>\n<p>Pharmacological Modulation of Cocaine Effects</p>\n</td>\n</tr>\n<tr>\n<th>Brief summary</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p>The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.</p>\n</td>\n</tr>\n<tr>\n<th>Detailed description</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p></p>\n</td>\n</tr>\n<tr>\n<th>Phase</th><td>Phase 2</td>\n</tr>\n<tr>\n<th>Study type</th><td>Interventional</td>\n</tr>\n<tr>\n<th>Study design</th><td>Treatment</td>\n</tr>\n<tr>\n<th>Condition</th><td>\n         Cocaine-Related Disorders\n      </td>\n</tr>\n<tr>\n<th>Intervention</th><td>\n<div>Drug: Selegiline</div>\n</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Recruitment Information</h2>\n</th>\n</tr>\n<tr>\n<th>Status</th><td>\n            Completed\n         </td>\n</tr>\n<tr>\n<th>End date</th><td>\n         2001-12\n      </td>\n</tr>\n<tr>\n<th>Criteria</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p>Please contact site for information.</p>\n</td>\n</tr>\n<tr>\n<th>Gender</th><td>\n            Female\n         </td>\n</tr>\n<tr>\n<th>Minimum age</th><td>N/A</td>\n</tr>\n<tr>\n<th>Maximum age</th><td>N/A</td>\n</tr>\n<tr>\n<th>Healthy volunteers</th><td>No</td>\n</tr>\n<tr>\n<th>Expected enrollment</th><td>0</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Administrative Data</h2>\n</th>\n</tr>\n<tr>\n<th>Organization name</th><td>National Institute on Drug Abuse (NIDA)</td>\n</tr>\n<tr>\n<th>Organization study ID</th><td>NIDA-05196-1</td>\n</tr>\n<tr>\n<th>Secondary ID</th><td>\n            R01-05196-1\n         </td>\n</tr>\n<tr>\n<th>Sponsor</th><td>\n               National Institute on Drug Abuse (NIDA)\n            </td>\n</tr>\n<tr>\n<th>Collaborator</th><td>\n               Johns Hopkins University\n            </td>\n</tr>\n<tr>\n<th>Health Authority</th><td>\n               United States: Federal Government\n         </td>\n</tr>\n</table>","asset":{"media":"","credit":"clinicaltrials.gov","caption":""}},{"startDate":"2005,06,30","headline":"View of NCT00000201 on 2005_06_30","text":"<body style=\"display:table; border-collapse:separate; border-spacing:10px;\"><div class=\"separation\" id=\"current\" style=\"display: table-cell; padding: 10px; border: 3px; border-style: solid; border-color: #bbbbbb;\"><table class=\"info\">\n<tr>\n<th nowrap=\"\">ClinicalTrials Identifier:</th><td>NCT00000201</td>\n</tr>\n<tr>\n<th>Updated:</th><td>2005_06_30</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Descriptive Information</h2>\n</th>\n</tr>\n<tr>\n<th>Brief title</th><td>\n<p>Pharmacological Modulation of Cocaine Effects - 1</p>\n</td>\n</tr>\n<tr>\n<th>Official title</th><td>\n<p>Pharmacological Modulation of Cocaine Effects</p>\n</td>\n</tr>\n<tr>\n<th>Brief summary</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p>The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.</p>\n</td>\n</tr>\n<tr>\n<th>Detailed description</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p></p>\n</td>\n</tr>\n<tr>\n<th>Phase</th><td>Phase 2</td>\n</tr>\n<tr>\n<th>Study type</th><td>Interventional</td>\n</tr>\n<tr>\n<th>Study design</th><td>Treatment</td>\n</tr>\n<tr>\n<th>Condition</th><td>\n         Cocaine-Related Disorders\n      </td>\n</tr>\n<tr>\n<th>Intervention</th><td>\n<div>Drug: Selegiline</div>\n</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Recruitment Information</h2>\n</th>\n</tr>\n<tr>\n<th>Status</th><td>\n            Completed\n         </td>\n</tr>\n<tr>\n<th>End date</th><td>\n         2001-12\n      </td>\n</tr>\n<tr>\n<th>Criteria</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p>Please contact site for information.</p>\n</td>\n</tr>\n<tr>\n<th>Gender</th><td>\n            Female\n         </td>\n</tr>\n<tr>\n<th>Minimum age</th><td>N/A</td>\n</tr>\n<tr>\n<th>Maximum age</th><td>N/A</td>\n</tr>\n<tr>\n<th>Healthy volunteers</th><td>No</td>\n</tr>\n<tr>\n<th>Expected enrollment</th><td>0</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Administrative Data</h2>\n</th>\n</tr>\n<tr>\n<th>Organization name</th><td>National Institute on Drug Abuse (NIDA)</td>\n</tr>\n<tr>\n<th>Organization study ID</th><td>NIDA-05196-1</td>\n</tr>\n<tr>\n<th>Secondary ID</th><td>\n            R01-05196-1\n         </td>\n</tr>\n<tr>\n<th>Sponsor</th><td>\n               National Institute on Drug Abuse (NIDA)\n            </td>\n</tr>\n<tr>\n<th>Collaborator</th><td>\n               Johns Hopkins University\n            </td>\n</tr>\n<tr>\n<th>Health Authority</th><td>\n               United States: Federal Government\n         </td>\n</tr>\n</table></div><div class=\"separation\" id=\"past\" style=\"display: table-cell; padding: 10px; border: 3px; border-style: solid; border-color: #bbbbbb;\"><html><body><span><table class=\"info\"><tr><th nowrap=\"\">ClinicalTrials Identifier:</th><td>NCT00000201</td></tr><tr><th>Updated:</th><td>2005_06_<del style=\"background:#ffe6e6;\">2</del><span>3</span><ins style=\"background:#e6ffe6;\">0</ins><span></span></td></tr><tr><th class=\"section\" colspan=\"2\"><h2>Descriptive Information</h2></th></tr><tr><th>Brief title</th><td><p>Pharmacological Modulation of Cocaine Effects - 1</p></td></tr><tr><th>Official title</th><td><p>Pharmacological Modulation of Cocaine Effects</p></td></tr><tr><th>Brief summary</th></tr><tr><td class=\"bigdent\" colspan=\"2\"><p>The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.</p></td></tr><tr><th>Detailed description</th></tr><tr><td class=\"bigdent\" colspan=\"2\"><p></p></td></tr><tr><th>Phase</th><td>Phase 2</td></tr><tr><th>Study type</th><td>Interventional</td></tr><tr><th>Study design</th><td>Treatment</td></tr><tr><th>Condition</th><td>         Cocaine-Related Disorders      </td></tr><tr><th>Intervention</th><td><div>Drug: Selegiline</div></td></tr><tr><th class=\"section\" colspan=\"2\"><h2>Recruitment Information</h2></th></tr><tr><th>Status</th><td>            Completed         </td></tr><tr><th>End date</th><td>         2001-12      </td></tr><tr><th>Criteria</th></tr><tr><td class=\"bigdent\" colspan=\"2\"><p>Please contact site for information.</p></td></tr><tr><th>Gender</th><td>            Female         </td></tr><tr><th>Minimum age</th><td>N/A</td></tr><tr><th>Maximum age</th><td>N/A</td></tr><tr><th>Healthy volunteers</th><td>No</td></tr><tr><th>Expected enrollment</th><td>0</td></tr><tr><th class=\"section\" colspan=\"2\"><h2>Administrative Data</h2></th></tr><tr><th>Organization name</th><td>National Institute on Drug Abuse (NIDA)</td></tr><tr><th>Organization study ID</th><td>NIDA-05196-1</td></tr><tr><th>Secondary ID</th><td>            R01-05196-1         </td></tr><tr><th>Sponsor</th><td>               National Institute on Drug Abuse (NIDA)            </td></tr><tr><th>Collaborator</th><td>               Johns Hopkins University            </td></tr><tr><th>Health Authority</th><td>               United States: Federal Government         </td></tr></table></span></body></html></div></body>","asset":{"media":"","credit":"clinicaltrials.gov","caption":""}},{"startDate":"2005,12,08","headline":"View of NCT00000201 on 2005_12_08","text":"<body style=\"display:table; border-collapse:separate; border-spacing:10px;\"><div class=\"separation\" id=\"current\" style=\"display: table-cell; padding: 10px; border: 3px; border-style: solid; border-color: #bbbbbb;\"><table class=\"info\">\n<tr>\n<th nowrap=\"\">ClinicalTrials Identifier:</th><td>NCT00000201</td>\n</tr>\n<tr>\n<th>Updated:</th><td>2005_12_08</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Descriptive Information</h2>\n</th>\n</tr>\n<tr>\n<th>Brief title</th><td>\n<p>Pharmacological Modulation of Cocaine Effects - 1</p>\n</td>\n</tr>\n<tr>\n<th>Official title</th><td>\n<p>Pharmacological Modulation of Cocaine Effects</p>\n</td>\n</tr>\n<tr>\n<th>Brief summary</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p>The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.</p>\n</td>\n</tr>\n<tr>\n<th>Detailed description</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p></p>\n</td>\n</tr>\n<tr>\n<th>Phase</th><td>Phase 2</td>\n</tr>\n<tr>\n<th>Study type</th><td>Interventional</td>\n</tr>\n<tr>\n<th>Study design</th><td>Treatment</td>\n</tr>\n<tr>\n<th>Condition</th><td>\n         Cocaine-Related Disorders\n      </td>\n</tr>\n<tr>\n<th>Intervention</th><td>\n<div>Drug: Selegiline</div>\n</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Recruitment Information</h2>\n</th>\n</tr>\n<tr>\n<th>Status</th><td>\n            Completed\n         </td>\n</tr>\n<tr>\n<th>End date</th><td>\n         2001-12\n      </td>\n</tr>\n<tr>\n<th>Criteria</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p>Please contact site for information.</p>\n</td>\n</tr>\n<tr>\n<th>Gender</th><td>\n            Female\n         </td>\n</tr>\n<tr>\n<th>Minimum age</th><td>N/A</td>\n</tr>\n<tr>\n<th>Maximum age</th><td>N/A</td>\n</tr>\n<tr>\n<th>Healthy volunteers</th><td>No</td>\n</tr>\n<tr>\n<th>Expected enrollment</th><td>0</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Administrative Data</h2>\n</th>\n</tr>\n<tr>\n<th>Organization name</th><td>National Institute on Drug Abuse (NIDA)</td>\n</tr>\n<tr>\n<th>Organization study ID</th><td>NIDA-05196-1</td>\n</tr>\n<tr>\n<th>Secondary ID</th><td>\n            R01-05196-1\n         </td>\n</tr>\n<tr>\n<th>Sponsor</th><td>\n               National Institute on Drug Abuse (NIDA)\n            </td>\n</tr>\n<tr>\n<th>Collaborator</th><td>\n               Johns Hopkins University\n            </td>\n</tr>\n<tr>\n<th>Health Authority</th><td>\n               United States: Federal Government\n         </td>\n</tr>\n</table></div><div class=\"separation\" id=\"past\" style=\"display: table-cell; padding: 10px; border: 3px; border-style: solid; border-color: #bbbbbb;\"><html><body><span><table class=\"info\"><tr><th nowrap=\"\">ClinicalTrials Identifier:</th><td>NCT00000201</td></tr><tr><th>Updated:</th><td>2005_<del style=\"background:#ffe6e6;\">06_30</del><ins style=\"background:#e6ffe6;\">12_08</ins><span></span></td></tr><tr><th class=\"section\" colspan=\"2\"><h2>Descriptive Information</h2></th></tr><tr><th>Brief title</th><td><p>Pharmacological Modulation of Cocaine Effects - 1</p></td></tr><tr><th>Official title</th><td><p>Pharmacological Modulation of Cocaine Effects</p></td></tr><tr><th>Brief summary</th></tr><tr><td class=\"bigdent\" colspan=\"2\"><p>The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.</p></td></tr><tr><th>Detailed description</th></tr><tr><td class=\"bigdent\" colspan=\"2\"><p></p></td></tr><tr><th>Phase</th><td>Phase 2</td></tr><tr><th>Study type</th><td>Interventional</td></tr><tr><th>Study design</th><td>Treatment</td></tr><tr><th>Condition</th><td>         Cocaine-Related Disorders      </td></tr><tr><th>Intervention</th><td><div>Drug: Selegiline</div></td></tr><tr><th class=\"section\" colspan=\"2\"><h2>Recruitment Information</h2></th></tr><tr><th>Status</th><td>            Completed         </td></tr><tr><th>End date</th><td>         2001-12      </td></tr><tr><th>Criteria</th></tr><tr><td class=\"bigdent\" colspan=\"2\"><p>Please contact site for information.</p></td></tr><tr><th>Gender</th><td>            Female         </td></tr><tr><th>Minimum age</th><td>N/A</td></tr><tr><th>Maximum age</th><td>N/A</td></tr><tr><th>Healthy volunteers</th><td>No</td></tr><tr><th>Expected enrollment</th><td>0</td></tr><tr><th class=\"section\" colspan=\"2\"><h2>Administrative Data</h2></th></tr><tr><th>Organization name</th><td>National Institute on Drug Abuse (NIDA)</td></tr><tr><th>Organization study ID</th><td>NIDA-05196-1</td></tr><tr><th>Secondary ID</th><td>            R01-05196-1         </td></tr><tr><th>Sponsor</th><td>               National Institute on Drug Abuse (NIDA)            </td></tr><tr><th>Collaborator</th><td>               Johns Hopkins University            </td></tr><tr><th>Health Authority</th><td>               United States: Federal Government         </td></tr></table></span></body></html></div></body>","asset":{"media":"","credit":"clinicaltrials.gov","caption":""}}]}}